Skip to main content
  • Home
  •  TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?

TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?

Topic:
  • Intervention
  • Structural Heart Disease

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
No ratings

Overview

This symposium hosted at Transcatheter Interventions Online 2024 explored cutting-edge advancements in coronary access and valve design within TAVI. Join Dr Darren Mylotte (Galway University Hospitals, Galway, IE), Dr Francesca Sanguineti (Cardiovascular Institute Paris Sud, Paris, FR), Dr Verena Veulemans (University Hospital Düsseldorf, Düsseldorf, DE), Prof David Hildick-Smith (Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK) as they analyse factors affecting coronary access across diverse valve designs and strategies to enhance access. This session provides step-by-step techniques for achieving optimal implant depth and implements guidelines for procedural confirmation in TAVI.

Support Statement

This symposium is supported by an unrestricted educational grant by Boston Scientific.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Medicl Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
 

The session, ‘TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 
 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionalsand the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.
 

Activities are designed to be completed within 90 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
 

To complete the course and claim certification participants must:
 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

Learning Objectives

Learning objectives

  • Evaluate the factors influencing coronary access in different valve designs
  • Formulate strategies to optimise coronary access based on valve characteristics
  • Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
  • Learn the step-by-step process for achieving optimum implant depth during TAVI
  • Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
Register now Log in

Module

Title

Duration

Speakers

Session 1 Welcome & Case Outline 7m 43s Darren Mylotte (Galway, IE)
Session 2 Considerations for TAVI Choice in Younger Patients 10m 35s Francesca Sanguineti (Paris, FR)
Session 3 Getting Optimum Implant Depth – Step-by-Step Guide 10m 35s Verena Veulemans (Düsseldorf, DE)
Session 4 Live Case and Panel Discussion 27m 14s David Hildick-Smith (Brighton, UK) Darren Mylotte (Galway, IE) Francesca Sanguineti (Paris, FR) Verena Veulemans (Düsseldorf, DE)
Session 1.

Welcome & Case Outline

Duration: 7m 43s

Speakers: Darren Mylotte (Galway, IE)

Session 2.

Considerations for TAVI Choice in Younger Patients

Duration: 10m 35s

Speakers: Francesca Sanguineti (Paris, FR)

Session 3.

Getting Optimum Implant Depth – Step-by-Step Guide

Duration: 10m 35s

Speakers: Verena Veulemans (Düsseldorf, DE)

Chair

Darren Mylotte

Galway University Hospitals, Galway, IE

Dr Darren Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme.

View full profile

Panelist

Verena Veulemans

Verena Veulemans

University Hospital Düsseldorf, Düsseldorf, DE

Verena Veulemans is an interventional cardiologist at University Hospital Düsseldorf, Germany. She joined the TAVR team in 2012 and has been a senior consultant since 2017. Dr Veulemans has led the interventional and transcatheter valve implantation/aortic disease research programme since 2018.

View full profile
 Francesca Sanguineti

Francesca Sanguineti

Cardiovascular Institute Paris Sud (ICPS), Paris, FR

Dr Francesca Sanguineti is an Interventional Cardiologist at the Institut Cardiovasculaire Paris Sud, Paris, FR. Born in Italy, she completed her medical studies at the University of Genoa, where she was captivated by cardiology and the swift and life-saving interventions.

View full profile

Operator

David Hildick-Smith

Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit.

View full profile
1.00 EBAC

TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice? programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Related Courses

TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
  • 1.00 EBAC

Learning objectives

  • Recall TAVI SMART trial data and the implications on clinical practice
  • Describe novel valve designs and the impact on long-term performance
  • Develop an expert-led approach to improving equitable access to TAVI
See more
Getting it Right First Time in Severe Aortic Stenosis - Key Insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
TIO 2023 – Debates
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Debates & Controversies – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Keynote & Debate
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Left Main & Bifurcations – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Left Main & Bifurcations
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Key Issues in TAVI - Live Cases and Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more